Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.99 USD
Change Today -0.32 / -1.96%
Volume 413.0K
EPZM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Gould Ph.D.

Chief Executive Officer, President, Secretary and Director, Epizyme, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 2 different industries.

See Board Relationships
59$1,958,381
As of Fiscal Year 2014

Background*

Dr. Robert J. Gould, Ph.D., has been the Chief Executive Officer of Epizyme, Inc. since March 2010 and has been its President since September 2014. Dr. Gould had been the Principal Financial Officer and Interim Treasurer of Epizyme, Inc. since October 1, 2014. He serves as Secretary of Epizyme, Inc. Dr. Gould served as the Vice President of Licensing and External Research at Merck Research Labs until 2006. Dr. Gould served as Vice President of Basic Research at Merck ...

Read Full Background

Corporate Headquarters*

400 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-229-5872
Fax: 617-349-0707

Board Members Memberships*

2008-Present
Chief Executive Officer, President, Secretary and Director

Education*

PhD
University of Iowa
Bachelor's Degree 1981
University of Iowa
BA 1976
Spring Arbor University

Other Affiliations*

Annual Compensation*

Salary$472,782
Bonus$180,000
Total Annual Compensation$652,782

Stock Options*

All Other Compensation$5,692
Exercisable Options783,272
Unexercisable Options230,507
Total Number of Options1,013,779

Total Compensation*

Total Annual Cash Compensation$658,474
Total Short Term Compensation$652,782
Other Long Term Compensation$5,692
Total Calculated Compensation$1,958,381
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EPZM:US $15.99 USD -0.32

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPIZYME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.